Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.

Authors:
Michael Soyka
Michael Soyka
Psychiatric Hospital
Germany

Expert Opin Drug Deliv 2015 Feb 25;12(2):339-47. Epub 2014 Aug 25.

Ludwig Maximilian University, Department of Psychiatry , Munich , Germany.

Introduction: Opioid dependence is a severe medical disorder with a high psychiatric and somatic comorbidity and mortality rate. The opioid agonist methadone, mixed agonist-antagonist buprenorphine and the combination of buprenorphine with the opioid antagonist naloxone are the first-line maintenance treatments for opioid dependence. Risk of diversion and accidental intoxications, especially in children, are of great concern. To lower these risks, a novel buprenorphine-naloxone film has been developed and introduced in the USA and Australia.

Areas Covered: This review evaluates the available preclinical and clinical data on the novel buprenorphine-naloxone film for treatment of opioid dependence. Literature was identified through a comprehensive PubMed search. Data sources also included official FDA information and material made public by the manufacturer.

Expert Opinion: Few preclinical and clinical data on safety and efficacy have been published. The pharmacological differences between the novel film and the conventional buprenorphine/naloxone are small. In an experimental study, the new formulation suppressed symptoms of opioid withdrawal. The spectrum of adverse events seems to be similar to that of the conventional sublingual tablet. Recent data show that patients prefer the novel film over the conventional sublingual tablet. Emerging surveillance data indicate a lower risk of accidental poisoning in children compared with the conventional formulation. Further clinical and preclinical data are needed to explore additional possible advantages of the new formulation.

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425247.2014.953479DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
February 2015
42 Reads

Publication Analysis

Top Keywords

opioid dependence
16
conventional sublingual
8
film conventional
8
preclinical clinical
8
clinical data
8
film treatment
8
treatment opioid
8
buprenorphine-naloxone film
8
sublingual tablet
8
novel film
8
novel buprenorphine-naloxone
8
opioid
7
data
6
film
5
manufacturerexpert opinion
4
material public
4
opinion preclinical
4
public manufacturerexpert
4
fda material
4
efficacy published
4

References

(Supplied by CrossRef)

United Nations Office on Drugs and Crime et al.
2006

European Monitoring Centre for Drugs and Drug Addiction et al.
2011
Article in Arch Gen Psychiatry
Kessler RC et al.
Arch Gen Psychiatry 2011
Article in Am J Psychiatry
Kleber HD et al.
Am J Psychiatry 2007

World Health Organization et al.
2004

Similar Publications